about
Clinical and neuroradiological features of spinocerebellar ataxia 38 (SCA38)Rom2-dependent phosphorylation of Elo2 controls the abundance of very long-chain fatty acids.Survival and severity in dominant cerebellar ataxias.Disruptive SCYL1 Mutations Underlie a Syndrome Characterized by Recurrent Episodes of Liver Failure, Peripheral Neuropathy, Cerebellar Atrophy, and Ataxia.Clinical Characteristics, Radiological Features and Gene Mutation in 10 Chinese Families with Spinocerebellar Ataxias.Desaturase and elongase-limiting endogenous long-chain polyunsaturated fatty acid biosynthesis.Genetic landscape remodelling in spinocerebellar ataxias: the influence of next-generation sequencing.The long tail and rare disease research: the impact of next-generation sequencing for rare Mendelian disorders.Nomenclature of genetic movement disorders: Recommendations of the international Parkinson and movement disorder society task force.Using the shared genetics of dystonia and ataxia to unravel their pathogenesis.Docosahexaenoic acid is a beneficial replacement treatment for spinocerebellar ataxia 38.Motor Deficits and Cerebellar Atrophy in Elovl5 Knock Out Mice.A Pentanucleotide ATTTC Repeat Insertion in the Non-coding Region of DAB1, Mapping to SCA37, Causes Spinocerebellar Ataxia.Exome sequencing and network analysis identifies shared mechanisms underlying spinocerebellar ataxia.Polyglutamine spinocerebellar ataxias - from genes to potential treatments.A panel study on patients with dominant cerebellar ataxia highlights the frequency of channelopathies.Clinical and Functional Characterization of a Missense ELF2 Variant in a CANVAS Family.
P2860
Q30379273-3BD6191F-3441-408D-95B3-61BFA0794C60Q35080312-641D92C4-3524-4DD2-80B1-B6D7974B2D17Q35115935-EADC29E6-F95C-47B4-8A5C-4471D1E2C2D1Q36369911-E19B3DFF-D22E-449D-A5B0-C0079134361BQ36523076-5207739E-76DA-4150-B822-65261C7A3AD5Q36623100-4A72746F-0CFD-4515-BAD6-2186B2D68C0BQ38415567-0F1F3A5E-4080-49A4-9469-F05BB14B573CQ38586076-BA95CD3C-0ECF-417E-9246-96CDC0C868DEQ38808532-06B42F85-0418-4C53-AF6D-B7D7428E12CAQ39112358-EFAD0E47-3CDD-4A8D-8C23-6F308CA61B67Q42694887-F98AFD86-8FB4-48D9-AF41-D7954841BC8EQ46210941-152E8BA5-8DFA-4FE9-8E0C-6852F8FD3B25Q47168134-7433D454-0F8B-4313-B745-8799C458E4D0Q47623915-F031DB2C-480D-4533-B45F-E98771F06A95Q47880472-8FE11CBD-F702-4C7B-82F7-78049215EA81Q51034720-A164950F-35A3-4C27-8602-CD75F861C47EQ52599667-E36EB41A-6856-48E8-A17F-B7119BF8227B
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
ELOVL5 mutations cause spinocerebellar ataxia 38
@ast
ELOVL5 mutations cause spinocerebellar ataxia 38
@en
ELOVL5 mutations cause spinocerebellar ataxia 38
@en-gb
ELOVL5 mutations cause spinocerebellar ataxia 38
@nl
type
label
ELOVL5 mutations cause spinocerebellar ataxia 38
@ast
ELOVL5 mutations cause spinocerebellar ataxia 38
@en
ELOVL5 mutations cause spinocerebellar ataxia 38
@en-gb
ELOVL5 mutations cause spinocerebellar ataxia 38
@nl
prefLabel
ELOVL5 mutations cause spinocerebellar ataxia 38
@ast
ELOVL5 mutations cause spinocerebellar ataxia 38
@en
ELOVL5 mutations cause spinocerebellar ataxia 38
@en-gb
ELOVL5 mutations cause spinocerebellar ataxia 38
@nl
P2093
P2860
P50
P3181
P1476
ELOVL5 mutations cause spinocerebellar ataxia 38
@en
P2093
Alessandro Calcia
Alessandro Padovani
Chiara Costanzi
Christelle Tesson
Daniela Lacerenza
Donatella Caruso
Eleonora Di Gregorio
Eleonora Duregon
Giovanna Vaula
Isabella Mura
P2860
P304
P3181
P356
10.1016/J.AJHG.2014.07.001
P407
P50
P5008
P577
2014-08-07T00:00:00Z